Consultant to Canadian Water Network Inc., Kitchener, Canada; Presently at Ontario Clean Water Agency, Mississauga, Canada.
Environmental Microbiology, BC Centre for Disease Control, Vancouver, Canada.
J Environ Sci (China). 2021 Sep;107:218-229. doi: 10.1016/j.jes.2021.01.029. Epub 2021 Mar 4.
Detection of SARS-CoV-2 RNA in wastewater is a promising tool for informing public health decisions during the COVID-19 pandemic. However, approaches for its analysis by use of reverse transcription quantitative polymerase chain reaction (RT-qPCR) are still far from standardized globally. To characterize inter- and intra-laboratory variability among results when using various methods deployed across Canada, aliquots from a real wastewater sample were spiked with surrogates of SARS-CoV-2 (gamma-radiation inactivated SARS-CoV-2 and human coronavirus strain 229E [HCoV-229E]) at low and high levels then provided "blind" to eight laboratories. Concentration estimates reported by individual laboratories were consistently within a 1.0-log range for aliquots of the same spiked condition. All laboratories distinguished between low- and high-spikes for both surrogates. As expected, greater variability was observed in the results amongst laboratories than within individual laboratories, but SARS-CoV-2 RNA concentration estimates for each spiked condition remained mostly within 1.0-log ranges. The no-spike wastewater aliquots provided yielded non-detects or trace levels (<20 gene copies/mL) of SARS-CoV-2 RNA. Detections appear linked to methods that included or focused on the solids fraction of the wastewater matrix and might represent in-situ SARS-CoV-2 to the wastewater sample. HCoV-229E RNA was not detected in the no-spike aliquots. Overall, all methods yielded comparable results at the conditions tested. Partitioning behavior of SARS-CoV-2 and spiked surrogates in wastewater should be considered to evaluate method effectiveness. A consistent method and laboratory to explore wastewater SARS-CoV-2 temporal trends for a given system, with appropriate quality control protocols and documented in adequate detail should succeed.
在 COVID-19 大流行期间,检测废水中的 SARS-CoV-2 RNA 是为公共卫生决策提供信息的一种很有前途的工具。然而,利用逆转录定量聚合酶链反应(RT-qPCR)对其进行分析的方法在全球范围内仍远未标准化。为了描述加拿大各地使用各种方法进行分析时结果的实验室间和实验室内变异性,将真实废水样本的等分试样用 SARS-CoV-2 的替代物(γ辐照灭活的 SARS-CoV-2 和人冠状病毒株 229E [HCoV-229E])进行低水平和高水平加标,然后提供给 8 个实验室。各个实验室报告的浓度估计值在相同加标条件的等分试样中始终在 1.0 对数范围内。所有实验室都能区分两种替代物的低水平和高水平加标。正如预期的那样,各实验室之间的结果差异较大,但每个加标条件的 SARS-CoV-2 RNA 浓度估计值大多仍在 1.0 对数范围内。未加标废水等分试样产生的 SARS-CoV-2 RNA 非检出或痕量水平(<20 个基因拷贝/mL)。检测到的 SARS-CoV-2 似乎与包括或侧重于废水基质固相部分的方法有关,并且可能代表了废水中的原位 SARS-CoV-2。在未加标等分试样中未检测到 HCoV-229E RNA。总体而言,在所测试的条件下,所有方法均产生可比的结果。应考虑 SARS-CoV-2 和加标替代物在废水中的分配行为,以评估方法的有效性。对于给定的系统,应使用一致的方法和实验室来探索废水 SARS-CoV-2 的时间趋势,并应遵循适当的质量控制协议并进行充分记录。